Skip to main content

Table 2 Power (%) of seven methods to detect association of rare variants under seven scenarios for underlying genetic architecture using data simulated for BRCA2 in 2000 cases and 2000 controls

From: The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

  

Threshold for significance

  

P < 0.001

P < 0.01

P < 0.05

Scenario*

Proportion of variants associated

RAML

SKAT-O

T1

T5

WST

VTT

EREC

RAML

SKAT-O

T1

T5

WST

VTT

EREC

RAML

SKAT-O

T1

T5

WST

VTT

EREC

1

0.05

19.5

2.5

0.5

2.5

1.5

4.5

5.5

41.0

7.5

6.0

7.0

6.0

14.5

11.0

57.5

18.0

21.5

15.0

15.5

29.5

18.5

2

0.05

15.5

4.5

1.5

3.0

2.0

3.0

5.0

26.5

9.5

3.0

6.0

7.0

7.5

10.0

44.0

21.0

14.0

15.0

11.5

18.5

18.0

3

0.05

13.0

2.5

0.5

2.0

2.0

2.5

2.5

27.5

4.0

4.0

4.0

2.5

3.5

4.5

45.5

13.5

15.5

8.0

9.0

17.0

11.5

4

0.05

14.0

3.5

1.5

2.5

1.5

3.5

3.0

27.0

9.5

4.0

6.5

6.0

7.5

8.5

39.5

18.5

7.5

13.5

13.5

16.0

16.0

5

0.05

14.5

3.0

0.5

2.0

1.5

2.5

3.5

31.0

8.0

3.0

5.5

3.5

7.0

8.0

47.0

12.5

15.0

10.5

9.0

17.0

13.0

6

0.05

15.0

2.5

0.5

0.5

1.0

1.5

1.0

30.0

9.5

4.0

7.0

7.0

4.0

9.0

45.5

21.0

8.0

17.0

15.0

14.0

21.0

7

0.05

18.0

0.5

0.0

0.5

0.0

1.5

1.5

29.5

2.5

3.0

1.0

1.0

3.0

2.5

44.0

9.0

8.5

5.0

3.5

9.0

10.0

1

0.10

14.5

1.5

3.0

1.5

2.5

7.5

3.5

30.5

8.0

13.0

6.0

8.0

15.5

8.5

48.5

19.0

24.0

14.5

20.5

31.0

20.0

2

0.10

9.5

2.0

1.0

1.5

2.0

3.5

3.0

24.5

10.5

4.5

7.0

7.5

8.5

9.0

40.0

22.0

15.5

18.0

19.5

18.5

23.0

3

0.10

11.5

1.5

1.5

1.0

2.0

3.0

2.5

27.0

5.0

9.0

4.0

4.5

8.5

6.0

41.5

12.5

20.5

10.5

10.5

22.5

13.5

4

0.10

11.0

3.0

2.0

2.5

1.0

2.5

2.5

20.5

7.0

4.0

5.0

3.5

9.5

5.5

39.5

18.0

13.0

11.5

12.5

16.0

14.0

5

0.10

13.5

2.5

3.0

1.5

2.0

3.5

2.5

24.0

6.0

6.0

4.0

3.0

9.0

7.0

40.5

18.0

15.5

12.0

13.5

18.0

14.5

6

0.10

6.5

0.5

0.0

0.0

0.0

0.0

0.5

17.0

4.5

1.0

2.5

3.0

3.0

3.5

36.0

13.0

7.0

7.5

8.5

11.5

10.5

7

0.10

7.5

1.5

1.5

2.0

1.0

3.0

2.0

22.5

4.0

5.0

4.0

4.0

8.0

4.0

40.5

15.5

13.5

9.0

10.5

17.0

13.0

1

0.20

20.0

9.0

12.0

9.5

12.0

22.5

11.0

41.0

18.0

27.0

17.0

25.0

39.5

21.0

59.0

31.5

47.5

28.0

38.0

55.0

30.0

2

0.20

8.5

1.0

2.5

0.5

1.5

4.5

2.5

22.0

5.5

11.0

5.0

8.0

13.5

7.0

45.0

18.5

27.0

12.0

21.5

30.0

17.0

3

0.20

9.0

3.0

5.0

3.0

6.5

9.0

4.0

25.5

9.0

17.5

9.0

13.0

20.0

10.5

44.5

17.0

34.0

16.0

22.0

34.5

19.5

4

0.20

8.5

1.0

1.0

0.5

1.0

1.5

1.0

21.5

6.5

6.0

4.0

6.0

9.0

5.5

38.0

15.0

16.0

13.0

12.0

20.5

17.5

5

0.20

12.5

4.0

2.5

4.0

1.0

4.5

4.0

29.0

8.0

5.5

6.0

6.0

12.5

8.5

43.5

17.5

17.5

14.0

15.0

24.0

18.0

6

0.20

5.5

2.0

1.0

2.5

1.0

2.5

3.0

21.5

4.0

3.0

5.0

3.5

7.0

6.0

35.0

15.5

12.0

10.0

11.0

15.5

15.0

7

0.20

8.5

2.5

1.0

1.5

1.0

1.5

3.0

21.0

6.0

3.0

5.0

5.0

3.5

7.0

42.0

16.5

9.0

13.0

12.5

14.0

16.0

  1. Method with greatest power emboldened.
  2. * See text for description of genetic architecture for each scenario.
  3. RAML Rare admixture maximum likelihood, SKAT-O sequence kernel association test, T1 fixed threshold test 1 per cent MAF, T5 fixed threshold test 5 per cent MAF, WST weighted sum test, VTT variable threshold test, EREC estimated regression coefficient test.